{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:14:23Z","timestamp":1779286463930,"version":"3.51.4"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10495-026-02322-1","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:58:43Z","timestamp":1778677123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic insights into ferroptosis in thyroid cancer and its therapeutic implications"],"prefix":"10.1007","volume":"31","author":[{"given":"Wenjie","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyue","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"2322_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1298","author":"E Cararo Lopes","year":"2023","unstructured":"Cararo Lopes E, Sawant A, Moore D, Ke H, Shi F, Laddha S, Chen Y, Sharma A, Naumann J, Guo JY, Gomez M, Ibrahim M, Smith TL, Riedlinger GM, Lattime EC, Trooskin S, Ganesan S, Su X, Pasqualini R, Arap W, De S, Chan CS, White E (2023) Integrated metabolic and genetic analysis reveals distinct features of human differentiated thyroid cancer. Clin Transl Med. https:\/\/doi.org\/10.1002\/ctm2.1298","journal-title":"Clin Transl Med"},{"issue":"4","key":"2322_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.suc.2024.02.003","volume":"104","author":"TD Fields","year":"2024","unstructured":"Fields TD, Underwood HJ, Pitt SC (2024) Management of Small Papillary Thyroid Cancers. Surg Clin North Am 104(4):725\u2013740","journal-title":"Surg Clin North Am"},{"issue":"11","key":"2322_CR3","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJMra1501993","volume":"375","author":"JA Fagin","year":"2016","unstructured":"Fagin JA, Wells SA Jr (2016) Biologic and Clinical Perspectives on Thyroid Cancer. N Engl J Med 375(11):1054\u20131067","journal-title":"N Engl J Med"},{"issue":"5","key":"2322_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072","journal-title":"Cell"},{"issue":"1","key":"2322_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2967\/jnumed.117.190819","volume":"60","author":"MC Kreissl","year":"2019","unstructured":"Kreissl MC, Janssen MJR, Nagarajah J (2019) Current treatment strategies in metastasized differentiated thyroid cancer. J Nucl Med 60(1):9\u201315","journal-title":"J Nucl Med"},{"issue":"1","key":"2322_CR6","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1186\/s12935-021-02389-7","volume":"21","author":"J Shi","year":"2021","unstructured":"Shi J, Wu P, Sheng L, Sun W, Zhang H (2021) Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma. Cancer Cell Int 21(1):669","journal-title":"Cancer Cell Int"},{"issue":"8","key":"2322_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B (2021) Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12(8):599\u2013620","journal-title":"Protein Cell"},{"issue":"1","key":"2322_CR8","first-page":"59","volume":"65","author":"B Zarebczan","year":"2010","unstructured":"Zarebczan B, Chen H (2010) Multi-targeted approach in the treatment of thyroid cancer. Minerva Chir 65(1):59\u201369","journal-title":"Minerva Chir"},{"issue":"3","key":"2322_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00268-018-4479-z","volume":"42","author":"Y Ito","year":"2018","unstructured":"Ito Y, Miyauchi A, Kihara M, Fukushima M, Higashiyama T, Miya A (2018) Overall survival of papillary thyroid carcinoma patients: A single-institution long-term follow-up of 5897 patients. World J Surg 42(3):615\u2013622","journal-title":"World J Surg"},{"issue":"1","key":"2322_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12957-018-1535-y","volume":"16","author":"L Shen","year":"2018","unstructured":"Shen L, Qian C, Cao H, Wang Z, Luo T, Liang C (2018) Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma. World J Surg Oncol 16(1):235","journal-title":"World J Surg Oncol"},{"issue":"9","key":"2322_CR11","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1089\/dna.2021.0216","volume":"40","author":"L Wang","year":"2021","unstructured":"Wang L, Zhang Y, Yang J, Liu L, Yao B, Tian Z, He J (2021) The knockdown of ETV4 inhibits the papillary thyroid cancer development by promoting ferroptosis upon SLC7A11 downregulation. DNA Cell Biol 40(9):1211\u20131221","journal-title":"DNA Cell Biol"},{"key":"2322_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.857765","volume":"13","author":"FH Ji","year":"2022","unstructured":"Ji FH, Fu XH, Li GQ, He Q, Qiu XG (2022) FTO prevents thyroid cancer progression by SLC7A11 m6A methylation in a ferroptosis-dependent manner. Front Endocrinol (Lausanne) 13:857765","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2322_CR13","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.suc.2009.06.021","volume":"89","author":"TA Moo-Young","year":"2009","unstructured":"Moo-Young TA, Traugott AL, Moley JF (2009) Sporadic and familial medullary thyroid carcinoma: state of the art. Surg Clin North Am 89(5):1193\u20131204","journal-title":"Surg Clin North Am"},{"issue":"2","key":"2322_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/107327480601300206","volume":"13","author":"KN Patel","year":"2006","unstructured":"Patel KN, Shaha AR (2006) Poorly differentiated and anaplastic thyroid cancer. Cancer Control 13(2):119\u2013128","journal-title":"Cancer Control"},{"key":"2322_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbrc.2021.02.126","volume":"551","author":"X Wang","year":"2021","unstructured":"Wang X, Xu S, Zhang L, Cheng X, Yu H, Bao J, Lu R (2021) Vitamin C induces ferroptosis in anaplastic thyroid cancer cells by ferritinophagy activation. Biochem Biophys Res Commun 551:46\u201353","journal-title":"Biochem Biophys Res Commun"},{"key":"2322_CR16","doi-asserted-by":"crossref","unstructured":"J. Wu, J. Liang, R. Liu, T. Lv, K. Fu, L. Jiang, W. Ma, Y. Pan, Z. Tan, Q. Liu, W. Qiu, M. Ge, J. Wang, Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer, Endocr Relat Cancer 30(9) (2023).","DOI":"10.1530\/ERC-23-0036"},{"key":"2322_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119908","volume":"348","author":"W He","year":"2025","unstructured":"He W, Hu X, Ge M, Meng K (2025) The central role of ferroptosis-induced therapy mediated by tenacissoside H in anaplastic thyroid cancer. J Ethnopharmacol 348:119908","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"2322_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/10738584221100183","volume":"29","author":"S David","year":"2023","unstructured":"David S, Ryan F, Jhelum P, Kroner A (2023) Ferroptosis in neurological disease. Neuroscientist 29(5):591\u2013615","journal-title":"Neuroscientist"},{"issue":"26","key":"2322_CR19","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","volume":"341","author":"NC Andrews","year":"1999","unstructured":"Andrews NC (1999) Disorders of iron metabolism. N Engl J Med 341(26):1986\u20131995","journal-title":"N Engl J Med"},{"issue":"10","key":"2322_CR20","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","volume":"13","author":"RJ Ward","year":"2014","unstructured":"Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 13(10):1045\u20131060","journal-title":"Lancet Neurol"},{"issue":"1","key":"2322_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J, Wang F, Min J (2023) Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther 8(1):372","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"2322_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao M, Monian P, Quadri N, Ramasamy R, Jiang X (2015) Glutaminolysis and transferrin regulate ferroptosis. Mol Cell 59(2):298\u2013308","journal-title":"Mol Cell"},{"issue":"2","key":"2322_CR23","first-page":"464","volume":"13","author":"Z Yang","year":"2023","unstructured":"Yang Z, Huang R, Wang Y, Guan Q, Li D, Wu Y, Liao T, Wang Y, Xiang J (2023) SIRT6 drives sensitivity to ferroptosis in anaplastic thyroid cancer through NCOA4-dependent autophagy. Am J Cancer Res 13(2):464\u2013474","journal-title":"Am J Cancer Res"},{"key":"2322_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.590226","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen X, Yu C, Kang R, Tang D (2020) Iron metabolism in ferroptosis. Front Cell Dev Biol 8:590226","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"2322_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, Kang R, Tang D (2016) Ferroptosis: process and function. Cell Death Differ 23(3):369\u2013379","journal-title":"Cell Death Differ"},{"issue":"3","key":"2322_CR26","first-page":"1650","volume":"25","author":"H Tu","year":"2021","unstructured":"Tu H, Tang LJ, Luo XJ, Ai KL, Peng J (2021) Insights into the novel function of system Xc- in regulated cell death. Eur Rev Med Pharmacol Sci 25(3):1650\u20131662","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"2322_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1476-5381.2011.01480.x","volume":"165","author":"RJ Bridges","year":"2012","unstructured":"Bridges RJ, Natale NR, Patel SA (2012) System xc\u207b cystine\/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol 165(1):20\u201334","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2322_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/cbf.3581","volume":"39","author":"L Liu","year":"2021","unstructured":"Liu L, Liu R, Liu Y, Li G, Chen Q, Liu X, Ma S (2021) Cystine-glutamate antiporter xCT as a therapeutic target for cancer. Cell Biochem Funct 39(2):174\u2013179","journal-title":"Cell Biochem Funct"},{"key":"2322_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.910292","volume":"13","author":"FJ Li","year":"2022","unstructured":"Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG, Gao LC (2022) System X(c) (-)\/GSH\/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol 13:910292","journal-title":"Front Pharmacol"},{"issue":"6","key":"2322_CR30","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.biotechadv.2014.04.004","volume":"32","author":"S Prasad","year":"2014","unstructured":"Prasad S, Gupta SC, Tyagi AK, Aggarwal BB (2014) Curcumin, a component of golden spice: from bedside to bench and back. Biotechnol Adv 32(6):1053\u20131064","journal-title":"Biotechnol Adv"},{"issue":"47","key":"2322_CR31","doi-asserted-by":"publisher","first-page":"32522","DOI":"10.1074\/jbc.M109.016139","volume":"284","author":"H Imai","year":"2009","unstructured":"Imai H, Hakkaku N, Iwamoto R, Suzuki J, Suzuki T, Tajima Y, Konishi K, Minami S, Ichinose S, Ishizaka K, Shioda S, Arata S, Nishimura M, Naito S, Nakagawa Y (2009) Depletion of selenoprotein GPx4 in spermatocytes causes male infertility in mice. J Biol Chem 284(47):32522\u201332532","journal-title":"J Biol Chem"},{"issue":"12","key":"2322_CR32","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch A, Eggenhofer E, Basavarajappa D, R\u00e5dmark O, Kobayashi S, Seibt T, Beck H, Neff F, Esposito I, Wanke R, F\u00f6rster H, Yefremova O, Heinrichmeyer M, Bornkamm GW, Geissler EK, Thomas SB, Stockwell BR, O\u2019Donnell VB, Kagan VE, Schick JA, Conrad M (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 16(12):1180\u20131191","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2322_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23906-2","volume":"12","author":"KR Sekhar","year":"2022","unstructured":"Sekhar KR, Hanna DN, Cyr S, Baechle JJ, Kuravi S, Balusu R, Rathmell K, Baregamian N (2022) Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer. Sci Rep 12(1):19396","journal-title":"Sci Rep"},{"issue":"1","key":"2322_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92369-8","volume":"11","author":"L Chen","year":"2021","unstructured":"Chen L, Na R, McLane KD, Thompson CS, Gao J, Wang X, Ran Q (2021) Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice. Sci Rep 11(1):12890","journal-title":"Sci Rep"},{"key":"2322_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228765","author":"CO Reichert","year":"2020","unstructured":"Reichert CO, de Freitas FA, Sampaio-Silva J, Rokita-Rosa L, Barros PL, Levy D, Bydlowski SP (2020) Ferroptosis Mechanisms Involved in Neurodegenerative Diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21228765","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2322_CR36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"2322_CR37","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.bbrc.2018.12.039","volume":"508","author":"Y Bai","year":"2019","unstructured":"Bai Y, Meng L, Han L, Jia Y, Zhao Y, Gao H, Kang R, Wang X, Tang D, Dai E (2019) Lipid storage and lipophagy regulates ferroptosis. Biochem Biophys Res Commun 508(4):997\u20131003","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2322_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A, Prokisch H, Tr\u00fcmbach D, Mao G, Qu F, Bayir H, F\u00fcllekrug J, Scheel CH, Wurst W, Schick JA, Kagan VE, Angeli JP, Conrad M (2017) ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol 13(1):91\u201398","journal-title":"Nat Chem Biol"},{"issue":"34","key":"2322_CR39","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR (2016) Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A 113(34):E4966\u2013E4975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2322_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2017.12.003","volume":"81","author":"RA DeBose-Boyd","year":"2018","unstructured":"DeBose-Boyd RA (2018) Significance and regulation of lipid metabolism. Semin Cell Dev Biol 81:97","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"2322_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.chom.2018.05.009","volume":"24","author":"R Kang","year":"2018","unstructured":"Kang R, Zeng L, Zhu S, Xie Y, Liu J, Wen Q, Cao L, Xie M, Ran Q, Kroemer G, Wang H, Billiar TR, Jiang J, Tang D (2018) Lipid peroxidation drives Gasdermin D-mediated pyroptosis in lethal polymicrobial sepsis. Cell Host Microbe 24(1):97-108.e4","journal-title":"Cell Host Microbe"},{"issue":"2","key":"2322_CR42","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","volume":"22","author":"H Lee","year":"2020","unstructured":"Lee H, Zandkarimi F, Zhang Y, Meena JK, Kim J, Zhuang L, Tyagi S, Ma L, Westbrook TF, Steinberg GR, Nakada D, Stockwell BR, Gan B (2020) Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat Cell Biol 22(2):225\u2013234","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2322_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00297-2","volume":"5","author":"C Li","year":"2020","unstructured":"Li C, Dong X, Du W, Shi X, Chen K, Zhang W, Gao M (2020) LKB1-AMPK axis negatively regulates ferroptosis by inhibiting fatty acid synthesis. Signal Transduct Target Ther 5(1):187","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"2322_CR44","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0167-7799(97)01077-9","volume":"15","author":"I Gill","year":"1997","unstructured":"Gill I, Valivety R (1997) Polyunsaturated fatty acids, Part 2: Biotransformations and biotechnological applications. Trends Biotechnol 15(11):470\u2013478","journal-title":"Trends Biotechnol"},{"issue":"10","key":"2322_CR45","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0167-7799(97)01076-7","volume":"15","author":"I Gill","year":"1997","unstructured":"Gill I, Valivety R (1997) Polyunsaturated fatty acids, Part 1: Occurrence, biological activities and applications. Trends Biotechnol 15(10):401\u2013409","journal-title":"Trends Biotechnol"},{"issue":"10","key":"2322_CR46","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1021\/cr200084z","volume":"111","author":"H Yin","year":"2011","unstructured":"Yin H, Xu L, Porter NA (2011) Free radical lipid peroxidation: mechanisms and analysis. Chem Rev 111(10):5944\u20135972","journal-title":"Chem Rev"},{"issue":"1","key":"2322_CR47","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1021\/cr60143a003","volume":"46","author":"CE Frank","year":"1950","unstructured":"Frank CE (1950) Hydrocarbon autoxidation. Chem Rev 46(1):155\u2013169","journal-title":"Chem Rev"},{"issue":"3","key":"2322_CR48","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","volume":"26","author":"L Magtanong","year":"2019","unstructured":"Magtanong L, Ko PJ, To M, Cao JY, Forcina GC, Tarangelo A, Ward CC, Cho K, Patti GJ, Nomura DK, Olzmann JA, Dixon SJ (2019) Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state. Cell Chem Biol 26(3):420-432.e9","journal-title":"Cell Chem Biol"},{"issue":"3-4","key":"2322_CR49","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12013-017-0799-0","volume":"75","author":"AW Girotti","year":"2017","unstructured":"Girotti AW, Korytowski W (2017) Cholesterol hydroperoxide generation, translocation, and reductive turnover in biological systems. Cell Biochem Biophys 75(3\u20134):413\u2013419","journal-title":"Cell Biochem Biophys"},{"issue":"7784","key":"2322_CR50","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, Bassik MC, Nomura DK, Dixon SJ, Olzmann JA (2019) The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575(7784):688\u2013692","journal-title":"Nature"},{"issue":"7784","key":"2322_CR51","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, Goya Grocin A, Xavier da Silva TN, Panzilius E, Scheel CH, Mour\u00e3o A, Buday K, Sato M, Wanninger J, Vignane T, Mohana V, Rehberg M, Flatley A, Schepers A, Kurz A, White D, Sauer M, Sattler M, Tate EW, Schmitz W, Schulze A, O\u2019Donnell V, Proneth B, Popowicz GM, Pratt DA, Angeli JPF, Conrad M (2019) FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575(7784):693\u2013698","journal-title":"Nature"},{"issue":"1-2","key":"2322_CR52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, Brown LM, Girotti AW, Cornish VW, Schreiber SL, Stockwell BR (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156(1\u20132):317\u2013331","journal-title":"Cell"},{"issue":"44","key":"2322_CR53","doi-asserted-by":"publisher","first-page":"E6806","DOI":"10.1073\/pnas.1607152113","volume":"113","author":"Y Ou","year":"2016","unstructured":"Ou Y, Wang SJ, Li D, Chu B, Gu W (2016) Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci U S A 113(44):E6806-e6812","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2322_CR54","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.celrep.2017.12.077","volume":"22","author":"A Tarangelo","year":"2018","unstructured":"Tarangelo A, Magtanong L, Bieging-Rolett KT, Li Y, Ye J, Attardi LD, Dixon SJ (2018) p53 suppresses metabolic stress-induced ferroptosis in cancer cells. Cell Rep 22(3):569\u2013575","journal-title":"Cell Rep"},{"issue":"2","key":"2322_CR55","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1582-4934.2003.tb00210.x","volume":"7","author":"T Thomas","year":"2003","unstructured":"Thomas T, Thomas TJ (2003) Polyamine metabolism and cancer. J Cell Mol Med 7(2):113\u2013126","journal-title":"J Cell Mol Med"},{"issue":"7","key":"2322_CR56","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.celrep.2017.07.055","volume":"20","author":"Y Xie","year":"2017","unstructured":"Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J, Zhong M, Yuan H, Zhang L, Billiar TR, Lotze MT, Zeh HJ 3rd, Kang R, Kroemer G, Tang D (2017) The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity. Cell Rep 20(7):1692\u20131704","journal-title":"Cell Rep"},{"issue":"45","key":"2322_CR57","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1038\/onc.2015.32","volume":"34","author":"X Sun","year":"2015","unstructured":"Sun X, Ou Z, Xie M, Kang R, Fan Y, Niu X, Wang H, Cao L, Tang D (2015) HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene 34(45):5617\u20135625","journal-title":"Oncogene"},{"issue":"7146","key":"2322_CR58","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature05859","volume":"447","author":"N Yagoda","year":"2007","unstructured":"Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM, Boniface JJ, Smith R, Lessnick SL, Sahasrabudhe S, Stockwell BR (2007) RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447(7146):864\u2013868","journal-title":"Nature"},{"key":"2322_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.112212","volume":"138","author":"B Huang","year":"2026","unstructured":"Huang B, Zhu C, Zhang X, Zhang Q, Wang H (2026) Ferroptosis modulation by METTL14 in cancers: from molecular insights to therapeutic strategies. Cell Signal 138:112212","journal-title":"Cell Signal"},{"key":"2322_CR60","doi-asserted-by":"publisher","DOI":"10.1039\/d5tb02738a","author":"Q Huang","year":"2026","unstructured":"Huang Q, Ma C, Wei P, Wang Q, Ren H, Li X (2026) Advances in Fenton Reaction-Mediated Ferroptosis for Enhanced Cancer Therapy: Mechanisms, Amplification Strategies, and Synergistic Approaches. Journal of Materials Chemistry B. https:\/\/doi.org\/10.1039\/d5tb02738a","journal-title":"Journal of Materials Chemistry B"},{"key":"2322_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD (2019) NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol 23:101107","journal-title":"Redox Biol"},{"issue":"1","key":"2322_CR62","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.abb.2011.02.001","volume":"508","author":"N Harada","year":"2011","unstructured":"Harada N, Kanayama M, Maruyama A, Yoshida A, Tazumi K, Hosoya T, Mimura J, Toki T, Maher JM, Yamamoto M, Itoh K (2011) Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages. Arch Biochem Biophys 508(1):101\u2013109","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"2322_CR63","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/84152","volume":"8","author":"CK Wu","year":"2001","unstructured":"Wu CK, Dailey HA, Rose JP, Burden A, Sellers VM, Wang BC (2001) The 2.0 A structure of human ferrochelatase, the terminal enzyme of heme biosynthesis. Nat Struct Biol 8(2):156\u2013160","journal-title":"Nat Struct Biol"},{"issue":"3","key":"2322_CR64","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10534-018-0111-9","volume":"31","author":"ET Zakharova","year":"2018","unstructured":"Zakharova ET, Sokolov AV, Pavlichenko NN, Kostevich VA, Abdurasulova IN, Chechushkov AV, Voynova IV, Elizarova AY, Kolmakov NN, Bass MG, Semak IV, Budevich AI, Kozhin PM, Zenkov NK, Klimenko VM, Kirik OV, Korzhevskii DE, Menshchikova EB, Vasilyev VB (2018) Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin. Biometals 31(3):425\u2013443","journal-title":"Biometals"},{"issue":"6","key":"2322_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2021.103163","volume":"42","author":"D Yang","year":"2021","unstructured":"Yang D, Wang J, Li C, Shi L, Zhang M (2021) Ferroptosis-related gene model to predict overall survival of papillary thyroid carcinoma. Am J Otolaryngol 42(6):103163","journal-title":"Am J Otolaryngol"},{"issue":"4","key":"2322_CR66","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s11010-022-04541-x","volume":"478","author":"W Li","year":"2023","unstructured":"Li W, Huang G, Wei J, Cao H, Jiang G (2023) ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2\/HO-1 axis. Mol Cell Biochem 478(4):729\u2013741","journal-title":"Mol Cell Biochem"},{"key":"2322_CR67","doi-asserted-by":"publisher","first-page":"6896790","DOI":"10.1155\/2023\/6896790","volume":"2023","author":"H Chen","year":"2023","unstructured":"Chen H, Li Z, Xu J, Zhang N, Chen J, Wang G, Zhao Y (2023) Curcumin Induces Ferroptosis in Follicular Thyroid Cancer by Upregulating HO-1 Expression. Oxid Med Cell Longev 2023:6896790","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"2322_CR68","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1530\/ERC-19-0074","volume":"26","author":"K Bergdorf","year":"2019","unstructured":"Bergdorf K, Ferguson DC, Mehrad M, Ely K, Stricker T, Weiss VL (2019) Papillary thyroid carcinoma behavior: clues in the tumor microenvironment. Endocr Relat Cancer 26(6):601\u2013614","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2322_CR69","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1080\/21655979.2021.1935400","volume":"12","author":"X Qian","year":"2021","unstructured":"Qian X, Tang J, Li L, Chen Z, Chen L, Chu Y (2021) A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma. Bioengineered 12(1):2341\u20132351","journal-title":"Bioengineered"},{"key":"2322_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.997873","volume":"13","author":"X Ren","year":"2022","unstructured":"Ren X, Du H, Cheng W, Wang Y, Xu Y, Yan S, Gao Y (2022) Construction of a ferroptosis-related eight gene signature for predicting the prognosis and immune infiltration of thyroid cancer. Front Endocrinol (Lausanne) 13:997873","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7755","key":"2322_CR71","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gij\u00f3n M, Kennedy PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, Xia H, Zhou J, Li G, Li J, Li W, Wei S, Vatan L, Zhang H, Szeliga W, Gu W, Liu R, Lawrence TS, Lamb C, Tanno Y, Cieslik M, Stone E, Georgiou G, Chan TA, Chinnaiyan A, Zou W (2019) CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569(7755):270\u2013274","journal-title":"Nature"},{"key":"2322_CR72","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001369","author":"I Efimova","year":"2020","unstructured":"Efimova I, Catanzaro E, Van der Meeren L, Turubanova VD, Hammad H, Mishchenko TA, Vedunova MV, Fimognari C, Bachert C, Coppieters F, Lefever S, Skirtach AG, Krysko O, Krysko DV (2020) Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-001369","journal-title":"J Immunother Cancer"},{"issue":"1","key":"2322_CR73","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12935-022-02674-z","volume":"22","author":"Y Qin","year":"2022","unstructured":"Qin Y, Zhang D, Zhang H, Hou L, Wang Z, Yang L, Zhang M, Zhao G, Yao Q, Ling R, Zhang J (2022) Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma. Cancer Cell Int 22(1):296","journal-title":"Cancer Cell Int"},{"issue":"5","key":"2322_CR74","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma X, Xiao L, Liu L, Ye L, Su P, Bi E, Wang Q, Yang M, Qian J, Yi Q (2021) CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metab 33(5):1001-1012.e5","journal-title":"Cell Metab"},{"issue":"2","key":"2322_CR75","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1158\/2326-6066.CIR-20-0384","volume":"9","author":"JM Drijvers","year":"2021","unstructured":"Drijvers JM, Gillis JE, Muijlwijk T, Nguyen TH, Gaudiano EF, Harris IS, LaFleur MW, Ringel AE, Yao CH, Kurmi K, Juneja VR, Trombley JD, Haigis MC, Sharpe AH (2021) Pharmacologic screening identifies metabolic vulnerabilities of CD8(+) T cells. Cancer Immunol Res 9(2):184\u2013199","journal-title":"Cancer Immunol Res"},{"issue":"19","key":"2322_CR76","doi-asserted-by":"publisher","first-page":"9533","DOI":"10.1073\/pnas.1814932116","volume":"116","author":"MD Arensman","year":"2019","unstructured":"Arensman MD, Yang XS, Leahy DM, Toral-Barza L, Mileski M, Rosfjord EC, Wang F, Deng S, Myers JS, Abraham RT, Eng CH (2019) Cystine-glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity. Proc Natl Acad Sci U S A 116(19):9533\u20139542","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2322_CR77","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1007\/s00262-023-03549-6","volume":"72","author":"L Zhu","year":"2023","unstructured":"Zhu L, Li XJ, Gangadaran P, Jing X, Ahn BC (2023) Tumor-associated macrophages as a potential therapeutic target in thyroid cancers. Cancer Immunol Immunother 72(12):3895\u20133917","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"2322_CR78","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","volume":"16","author":"AA Kapralov","year":"2020","unstructured":"Kapralov AA, Yang Q, Dar HH, Tyurina YY, Anthonymuthu TS, Kim R, St Croix CM, Mikulska-Ruminska K, Liu B, Shrivastava IH, Tyurin VA, Ting HC, Wu YL, Gao Y, Shurin GV, Artyukhova MA, Ponomareva LA, Timashev PS, Domingues RM, Stoyanovsky DA, Greenberger JS, Mallampalli RK, Bahar I, Gabrilovich DI, Bay\u0131r H, Kagan VE (2020) Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat Chem Biol 16(3):278\u2013290","journal-title":"Nat Chem Biol"},{"key":"2322_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1581951","volume":"15","author":"W Liu","year":"2025","unstructured":"Liu W, Jing Y, Chen Y, Sun H, Xu W, Liang R, Liu W, Zhang Z, Liu H (2025) Research progress on the cross-regulation between ferroptosis and immunogenic cell death in tumor micro-environment. Front Oncol 15:1581951","journal-title":"Front Oncol"},{"key":"2322_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061511","author":"N Miazek-Zapala","year":"2021","unstructured":"Miazek-Zapala N, Slusarczyk A, Kusowska A, Zapala P, Kubacz M, Winiarska M, Bobrowicz M (2021) The \u201cMagic Bullet\u201d Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era. Cells. https:\/\/doi.org\/10.3390\/cells10061511","journal-title":"Cells"},{"key":"2322_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1230534","volume":"14","author":"SM Cruz","year":"2023","unstructured":"Cruz SM, Sholevar CJ, Judge SJ, Darrow MA, Iranpur KR, Farley LE, Lammers M, Razmara AM, Dunai C, Gingrich AA, Persky J, Mori H, Thorpe SW, Monjazeb AM, Murphy WJ, Canter RJ (2023) Intratumoral NKp46(+) natural killer cells are spatially distanced from T and MHC-I(+) cells with prognostic implications in soft tissue sarcoma. Front Immunol 14:1230534","journal-title":"Front Immunol"},{"key":"2322_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104907","volume":"214","author":"M Ebrahimnezhad","year":"2025","unstructured":"Ebrahimnezhad M, Valizadeh A, Yousefi B (2025) Ferroptosis and immunotherapy: breaking barriers in cancer treatment resistance. Crit Rev Oncol Hematol 214:104907","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"2322_CR83","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.7150\/ijbs.85753","volume":"19","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhang J, Luan S, Liu Z, Li X, Liu B, Yuan Y (2023) Unraveling the complexity of regulated cell death in esophageal cancer: from underlying mechanisms to targeted therapeutics. Int J Biol Sci 19(12):3831\u20133868","journal-title":"Int J Biol Sci"},{"issue":"1-2","key":"2322_CR84","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11010-020-03806-7","volume":"473","author":"MM Uddin","year":"2020","unstructured":"Uddin MM, Ibrahim MMH, Aryal D, Briski KP (2020) Sex-dimorphic moderate hypoglycemia preconditioning effects on hippocampal CA1 neuron bio-energetic and anti-oxidant function. Mol Cell Biochem 473(1\u20132):39\u201350","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"2322_CR85","doi-asserted-by":"publisher","first-page":"230","DOI":"10.18632\/aging.204473","volume":"15","author":"H Chen","year":"2023","unstructured":"Chen H, Peng F, Xu J, Wang G, Zhao Y (2023) Increased expression of GPX4 promotes the tumorigenesis of thyroid cancer by inhibiting ferroptosis and predicts poor clinical outcomes. Aging (Albany NY) 15(1):230\u2013245","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"2322_CR86","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00268-022-06738-z","volume":"47","author":"KR Sekhar","year":"2023","unstructured":"Sekhar KR, Cyr S, Baregamian N (2023) Ferroptosis inducers in thyroid cancer. World J Surg 47(2):371\u2013381","journal-title":"World J Surg"},{"issue":"5","key":"2322_CR87","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/ddr.22059","volume":"84","author":"D Pamarthy","year":"2023","unstructured":"Pamarthy D, Behera SK, Swain S, Yadav S, Suresh S, Jain N, Bhadra MP (2023) Diaryl ether derivative inhibits GPX4 expression levels to induce ferroptosis in thyroid cancer cells. Drug Dev Res 84(5):861\u2013887","journal-title":"Drug Dev Res"},{"key":"2322_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.586578","volume":"8","author":"F Kuang","year":"2020","unstructured":"Kuang F, Liu J, Tang D, Kang R (2020) Oxidative damage and antioxidant defense in ferroptosis. Front Cell Dev Biol 8:586578","journal-title":"Front Cell Dev Biol"},{"key":"2322_CR89","doi-asserted-by":"crossref","unstructured":"C. Abe, T. Miyazawa, T. Miyazawa, Current Use of Fenton Reaction in Drugs and Food, Molecules 27(17) (2022).","DOI":"10.3390\/molecules27175451"},{"key":"2322_CR90","doi-asserted-by":"crossref","unstructured":"Z. Zhou, B. You, C. Ji, L. Zhang, F. Wu, H. Qian, Implications of Crosstalk between Exosome-Mediated Ferroptosis and Diseases for Pathogenesis and Treatment, Cells 12(2) (2023).","DOI":"10.3390\/cells12020311"},{"issue":"1","key":"2322_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-01218-8","volume":"8","author":"D Gong","year":"2022","unstructured":"Gong D, Chen M, Wang Y, Shi J, Hou Y (2022) Role of ferroptosis on tumor progression and immunotherapy. Cell Death Discov 8(1):427","journal-title":"Cell Death Discov"},{"issue":"Pt 1","key":"2322_CR92","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2023.10.015","volume":"209","author":"M Inoue","year":"2023","unstructured":"Inoue M, Iizuka Y, Nakamura K, Sato GE, Mizowaki T (2023) Role of albumin Cys34 redox state in the progression of differentiated thyroid carcinoma and induction of ferroptosis. Free Radic Biol Med 209(Pt 1):108\u2013115","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"2322_CR93","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/ijc.33690","volume":"149","author":"F Nabhan","year":"2021","unstructured":"Nabhan F, Dedhia PH, Ringel MD (2021) Thyroid cancer, recent advances in diagnosis and therapy. Int J Cancer 149(5):984\u2013992","journal-title":"Int J Cancer"},{"issue":"13","key":"2322_CR94","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA 317(13):1338\u20131348","journal-title":"JAMA"},{"issue":"1","key":"2322_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1):1\u2013133","journal-title":"Thyroid"},{"issue":"3","key":"2322_CR96","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/thy.2020.0944","volume":"31","author":"KC Bible","year":"2021","unstructured":"Bible KC, Kebebew E, Brierley J, Brito JP, Cabanillas ME, Clark TJ Jr., Di Cristofano A, Foote R, Giordano T, Kasperbauer J, Newbold K, Nikiforov YE, Randolph G, Rosenthal MS, Sawka AM, Shah M, Shaha A, Smallridge R, Wong-Clark CK (2021) 2021 American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid 31(3):337\u2013386","journal-title":"Thyroid"},{"issue":"6","key":"2322_CR97","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr.","year":"2015","unstructured":"Wells SA Jr., Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25(6):567\u2013610","journal-title":"Thyroid"},{"issue":"5","key":"2322_CR98","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S2213-8587(13)70215-8","volume":"2","author":"M Schlumberger","year":"2014","unstructured":"Schlumberger M, Brose M, Elisei R, Leboulleux S, Luster M, Pitoia F, Pacini F (2014) Definition and management of radioactive iodine-refractory differentiated thyroid cancer. Lancet Diabetes Endocrinol 2(5):356\u2013358","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"2322_CR99","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1089\/thy.2012.0302","volume":"22","author":"RC Smallridge","year":"2012","unstructured":"Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal MS, Shah MH, Shaha AR, Tuttle RM (2012) American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid 22(11):1104\u20131139","journal-title":"Thyroid"},{"issue":"9940","key":"2322_CR100","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","volume":"384","author":"MS Brose","year":"2014","unstructured":"Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R, Shong YK, Sherman SI, Smit JW, Chung J, Kappeler C, Pe\u00f1a C, Moln\u00e1r I, Schlumberger MJ (2014) Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet 384(9940):319\u2013328","journal-title":"Lancet"},{"issue":"9","key":"2322_CR101","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJMoa2005651","volume":"383","author":"LJ Wirth","year":"2020","unstructured":"Wirth LJ, Sherman E, Robinson B, Solomon B, Kang H, Lorch J, Worden F, Brose M, Patel J, Leboulleux S, Godbert Y, Barlesi F, Morris JC, Owonikoko TK, Tan DSW, Gautschi O, Weiss J, de la Fouchardi\u00e8re C, Burkard ME, Laskin J, Taylor MH, Kroiss M, Medioni J, Goldman JW, Bauer TM, Levy B, Zhu VW, Lakhani N, Moreno V, Ebata K, Nguyen M, Heirich D, Zhu EY, Huang X, Yang L, Kherani J, Rothenberg SM, Drilon A, Subbiah V, Shah MH, Cabanillas ME (2020) Efficacy of Selpercatinib in RET-altered thyroid cancers. N Engl J Med 383(9):825\u2013835","journal-title":"N Engl J Med"},{"issue":"29","key":"2322_CR102","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1200\/JCO.2012.48.4659","volume":"31","author":"R Elisei","year":"2013","unstructured":"Elisei R, Schlumberger MJ, M\u00fcller SP, Sch\u00f6ffski P, Brose MS, Shah MH, Licitra L, Jarzab B, Medvedev V, Kreissl MC, Niederle B, Cohen EE, Wirth LJ, Ali H, Hessel C, Yaron Y, Ball D, Nelkin B, Sherman SI (2013) Cabozantinib in progressive medullary thyroid cancer. J Clin Oncol 31(29):3639\u20133646","journal-title":"J Clin Oncol"},{"key":"2322_CR103","doi-asserted-by":"crossref","unstructured":"M. Schlumberger, M. Tahara, L.J. Wirth, B. Robinson, M.S. Brose, R. Elisei, M.A. Habra, K. Newbold, M.H. Shah, A.O. Hoff, A.G. Gianoukakis, N. Kiyota, M.H. Taylor, S.B. Kim, M.K. Krzyzanowska, C.E. Dutcus, B. de las Heras, J. Zhu, S.I. Sherman, Lenvatinib versus placebo in radioiodine-refractory thyroid cancer, N Engl J Med 372(7) (2015) 621\u201330.","DOI":"10.1056\/NEJMoa1406470"},{"key":"2322_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1580828","volume":"15","author":"L Ling","year":"2025","unstructured":"Ling L, Zhang J, Zhang X, Wang P, Ma M, Yin B (2025) Iodine-131 induces ferroptosis and synergizes with sulfasalazine in differentiated thyroid cancer cells via suppressing SLC7A11. Front Oncol 15:1580828","journal-title":"Front Oncol"},{"key":"2322_CR105","first-page":"7933775","volume":"2022","author":"S Li","year":"2022","unstructured":"Li S, Zhang Y, Zhang J, Yu B, Wang W, Jia B, Chang J, Liu J (2022) Neferine Exerts Ferroptosis-Inducing Effect and Antitumor Effect on Thyroid Cancer through Nrf2\/HO-1\/NQO1 Inhibition. J Oncol 2022:7933775","journal-title":"J Oncol"},{"key":"2322_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117912","volume":"326","author":"Y Gao","year":"2024","unstructured":"Gao Y, Yang Z, Ji T, Zhou P, Geng L, Gao X (2024) Anti-papillary thyroid carcinoma effects of dioscorea bulbifera L. through ferroptosis and the PI3K\/AKT pathway based on network pharmacology and experimental validation. J Ethnopharmacol 326:117912","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"2322_CR107","first-page":"7463","volume":"9","author":"L Sun","year":"2024","unstructured":"Sun L, Zheng G, Zhou M, Zhang Y, Yang Y, Zhang S, Gao L (2024) In vitro ferroptotic and antitumor effect of free or liposome-encapsulated artesunate in papillary thyroid cancer cells. ACS Omega 9(7):7463\u20137470","journal-title":"ACS Omega"},{"key":"2322_CR108","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x2024e13679","volume":"57","author":"S Lin","year":"2024","unstructured":"Lin S, Cai H, Song X (2024) Synergy between isobavachalcone and doxorubicin suppressed the progression of anaplastic thyroid cancer through ferroptosis activation. Braz J Med Biol Res 57:e13679","journal-title":"Braz J Med Biol Res"},{"issue":"28","key":"2322_CR109","doi-asserted-by":"publisher","first-page":"31099","DOI":"10.1021\/acsomega.5c04710","volume":"10","author":"L Liang","year":"2025","unstructured":"Liang L, Chen Z, Lei D, Mo C, Lan D, Ke J, Wang W, Yang Z, Guo X, Chen D, Zhao Y, Chen H (2025) APG-115 induces SLC7A11-mediated ferroptosis and upregulates PD-L1 expression in thyroid cancer. ACS Omega 10(28):31099\u201331107","journal-title":"ACS Omega"},{"issue":"1","key":"2322_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03947-z","volume":"25","author":"Y Guo","year":"2025","unstructured":"Guo Y, Liang J, Ding L, Wu J, Teng W, Wang J, Jiang L, Tan Z (2025) The endoplasmic reticulum stress-ferroptosis reciprocal signaling orchestrates anti-tumor effect of anlotinib in anaplastic thyroid cancer. Cancer Cell Int 25(1):310","journal-title":"Cancer Cell Int"},{"key":"2322_CR111","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2024.13359","author":"X Jin","year":"2024","unstructured":"Jin X, Zhu H, Chen X, Yang Y, Song D (2024) RON receptor tyrosine kinase regulates glycolysis through MAPK\/CREB signaling to affect ferroptosis and chemotherapy sensitivity of thyroid cancer cells. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2024.13359","journal-title":"Mol Med Rep"},{"issue":"1","key":"2322_CR112","doi-asserted-by":"publisher","first-page":"128","DOI":"10.7150\/ijbs.99423","volume":"21","author":"X Chen","year":"2025","unstructured":"Chen X, Chen X, Xie W, Ge H, He H, Zhang A, Zheng J (2025) BRAF-activated ARSI suppressed EREG-mediated ferroptosis to promote BRAF(V600E) (mutant) papillary thyroid carcinoma progression and sorafenib resistance. Int J Biol Sci 21(1):128\u2013142","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2322_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03275-8","volume":"24","author":"Y Huang","year":"2024","unstructured":"Huang Y, Du J, Li D, He W, Liu Z, Liu L, Yang X, Cheng X, Chen R, Yang Y (2024) LASS2 suppresses metastasis in multiple cancers by regulating the ferroptosis signalling pathway through interaction with TFRC. Cancer Cell Int 24(1):87","journal-title":"Cancer Cell Int"},{"issue":"6","key":"2322_CR114","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1111\/cas.70039","volume":"116","author":"HM Zhang","year":"2025","unstructured":"Zhang HM, Li HN, Qi E, Yang Y, Ma H, Ma J, Xiong X, Wang J, Yang ZF, Liao XH (2025) GGCT inhibits ferroptosis in PTC cells by upregulating p53 through RPS15A. Cancer Sci 116(6):1592\u20131603","journal-title":"Cancer Sci"},{"key":"2322_CR115","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.freeradbiomed.2025.02.025","volume":"231","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Zhou D, Qiu X, Xia F, Li X (2025) N6-methyladenosine-mediated EIF3H promotes anaplastic thyroid cancer progression and ferroptosis resistance by stabilizing \u03b2-catenin. Free Radic Biol Med 231:38\u201347","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"2322_CR116","doi-asserted-by":"publisher","first-page":"16500","DOI":"10.18632\/aging.203172","volume":"13","author":"W Chen","year":"2021","unstructured":"Chen W, Fu J, Chen Y, Li Y, Ning L, Huang D, Yan S, Zhang Q (2021) Circular RNA circKIF4A facilitates the malignant progression and suppresses ferroptosis by sponging miR-1231 and upregulating GPX4 in papillary thyroid cancer. Aging (Albany NY) 13(12):16500\u201316512","journal-title":"Aging (Albany NY)"},{"key":"2322_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.670031","volume":"12","author":"HH Wang","year":"2021","unstructured":"Wang HH, Ma JN, Zhan XR (2021) Circular RNA Circ_0067934 attenuates ferroptosis of thyroid cancer cells by miR-545-3p\/SLC7A11 signaling. Front Endocrinol (Lausanne) 12:670031","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2322_CR118","first-page":"426","volume":"52","author":"T Huang","year":"2022","unstructured":"Huang T, Guan S, Wang C (2022) CERS6-AS1 facilitates oncogenesis and restrains ferroptosis in Papillary Thyroid Carcinoma by serving as a ceRNA through miR-497-5p\/LASP1 axis. Ann Clin Lab Sci 52(3):426\u2013438","journal-title":"Ann Clin Lab Sci"},{"issue":"2","key":"2322_CR119","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/dna.2024.0197","volume":"44","author":"L Luo","year":"2025","unstructured":"Luo L, Sun Y, Cao Z (2025) METTL3-induced m6A modification enhances Hsa_Circ_0136959 expression to impair the tumor characteristics of Papillary Thyroid Carcinoma via accelerating ferroptosis. DNA Cell Biol 44(2):99\u2013108","journal-title":"DNA Cell Biol"},{"issue":"1","key":"2322_CR120","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-025-10073-z","volume":"41","author":"Z Li","year":"2025","unstructured":"Li Z, Ma J, Guan H, Lai J, Xu F, Cao G (2025) FTO-mediated the destabilization of RASGRF1 mRNA impedes thyroid cancer progression and suppresses macrophage M2 polarization. Cell Biol Toxicol 41(1):123","journal-title":"Cell Biol Toxicol"},{"issue":"12","key":"2322_CR121","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1007\/s40618-024-02385-4","volume":"47","author":"J Ma","year":"2024","unstructured":"Ma J, Li Z, Xu J, Lai J, Zhao J, Ma L, Sun X (2024) PRDM1 promotes the ferroptosis and immune escape of thyroid cancer by regulating USP15-mediated SELENBP1 deubiquitination. J Endocrinol Invest 47(12):2981\u20132997","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2322_CR122","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/tox.23992","volume":"39","author":"F Lian","year":"2024","unstructured":"Lian F, Dong D, Pu J, Yang G, Yang J, Yang S, Wang Y, Zhao B, Lu M (2024) Ubiquitin-specific peptidase 10 attenuates the ferroptosis to promote thyroid cancer malignancy by facilitating GPX4 via elevating SIRT6. Environ Toxicol 39(3):1129\u20131139","journal-title":"Environ Toxicol"},{"key":"2322_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1478395","volume":"15","author":"YY Ma","year":"2024","unstructured":"Ma YY, Zhou WY, Qian Y, Mu YY, Zhang W (2024) SOX13 as a potential prognostic biomarker linked to immune infiltration and ferroptosis inhibits the proliferation, migration, and metastasis of thyroid cancer cells. Front Immunol 15:1478395","journal-title":"Front Immunol"},{"key":"2322_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/genes13060997","author":"Y Wang","year":"2022","unstructured":"Wang Y, Yang J, Chen S, Wang W, Teng L (2022) Identification and Validation of a Prognostic Signature for Thyroid Cancer Based on Ferroptosis-Related Genes. Genes (Basel). https:\/\/doi.org\/10.3390\/genes13060997","journal-title":"Genes (Basel)"},{"issue":"1","key":"2322_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-87059-8","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhang Y, Liu M, Liu Y, Zeng Y, Zhang W, Wu S, Hu L, Ruan X, Zheng X, Gao M, Zhao J (2025) Programmed cell death-related gene IL20RA facilitates tumor progression and remodels tumor microenvironment in thyroid cancer. Sci Rep 15(1):3520","journal-title":"Sci Rep"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02322-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02322-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02322-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:04:15Z","timestamp":1779285855000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02322-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":125,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2322"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02322-1","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"141"}}